Nathalie Alos

Summary

Affiliation: University of Montreal
Country: Canada

Publications

  1. ncbi Rising serum thyroxine levels and chorea in graves' disease
    Coralie Leblicq
    Endocrinology and Bone Metabolism Service, Department of Pediatrics, CHU Sainte Justine, 3175 chemin de la Cote Sainte Catherine, H3T 1C5 Montreal, PQ, Canada
    Pediatrics 131:e616-9. 2013
  2. ncbi Downregulation of osteoblast Phex expression by PTH
    Nathalie Alos
    Genetics Unit, Shriners Hospital, Departments of Surgery and Human Genetics, McGill University, Montreal, Quebec, Canada
    Bone 37:589-98. 2005
  3. ncbi Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis
    Nathalie Alos
    Endocrinology Service, Sainte Justine Hospital and Research Center, Universite de Montreal, Montreal, Quebec, Canada
    Horm Res 65:289-94. 2006

Collaborators

  • Coralie Leblicq
  • Lionel Carmant
  • Guy Van Vliet
  • Michel Duval

Detail Information

Publications3

  1. ncbi Rising serum thyroxine levels and chorea in graves' disease
    Coralie Leblicq
    Endocrinology and Bone Metabolism Service, Department of Pediatrics, CHU Sainte Justine, 3175 chemin de la Cote Sainte Catherine, H3T 1C5 Montreal, PQ, Canada
    Pediatrics 131:e616-9. 2013
    ..Therefore, chorea in this patient is associated with hyperthyroxinemia and not with autoantibodies...
  2. ncbi Downregulation of osteoblast Phex expression by PTH
    Nathalie Alos
    Genetics Unit, Shriners Hospital, Departments of Surgery and Human Genetics, McGill University, Montreal, Quebec, Canada
    Bone 37:589-98. 2005
    ..The downregulation of Phex expression by PTH in vitro is associated with inhibition of matrix mineralization, consistent with a role for Phex in bone mineralization...
  3. ncbi Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis
    Nathalie Alos
    Endocrinology Service, Sainte Justine Hospital and Research Center, Universite de Montreal, Montreal, Quebec, Canada
    Horm Res 65:289-94. 2006
    ..Only one report has described the use of intravenous bisphosphonates for this condition. We propose that pamidronate could be the first line therapy for severe hypercalcemia in SCFN...